当前位置:
X-MOL 学术
›
Blood Cancer J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2019-07-25 , DOI: 10.1038/s41408-019-0214-8 Sausan A. Moharram , Kinjal Shah , Fatima Khanum , Lars Rönnstrand , Julhash U. Kazi
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2019-07-25 , DOI: 10.1038/s41408-019-0214-8 Sausan A. Moharram , Kinjal Shah , Fatima Khanum , Lars Rönnstrand , Julhash U. Kazi
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
中文翻译:
更正:ALK抑制剂AZD3463有效抑制索拉非尼耐药的急性髓性白血病的生长
该论文的修订版已经发布,可以通过本文顶部的链接进行访问。
更新日期:2019-11-18
中文翻译:
更正:ALK抑制剂AZD3463有效抑制索拉非尼耐药的急性髓性白血病的生长
该论文的修订版已经发布,可以通过本文顶部的链接进行访问。